The tilting- disc Heart Valve, after
successful clinical trials is now commercially available,
an indigenously developed remedy which holds a lot of
promise for persons with Heart Valve problems especially
those suffering from rheumatic heart diseases, for blocked
or leaking aortal and mitral passages in the heart.
The technology, conceived and crafted by the Sree Chitra
Tirunal Institute of Medical Sciences and Technology
(SCTIMST), Thiruvananthapuram, was transferred by the
funding agency, the National Research Development Corporation
(NRDC) to TTK Pharma for commercial exploitation based
on its experience in the big?medical devices field.
The heart valve's launch is a culmination of more than
15 years of painstaking research and development TTK
Pharma is the third company in the world to produce
such a heart valve. Artificial heart valves implanted
in patients in India (many of them are children who
suffer from rheumatic fever) till two years back were
imported at a price which rang
Raw Materials:
In the Indian context, the durability
of the valve is of paramount importance because the
average age of RHO patients is between 20 and 30 years,
whereas in the developed countries patients are mostly
Contact
for more information
Director National Research Development Corporation
20-22, Zamroodpur Community CentreKailash Colony Extension
New Delhi, India
Delhi 110048
Tel: 11 6449401/6460506
Fax: 11 6432121/6449396
Email: info@nrdcindia.com
